News | April 27, 2022
Lasa Supergenerics bags Rs. 50 crore orders
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
The demand for high-quality paediatric medicines has been growing rapidly in China as a result of the government’s support and policy measures
Tembo and UFlex-Asepto have co-developed 100% renewable and recyclable paper straw solution that will be food grade, moisture-resistant and made from sustainably sourced papers
Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers
The StealthStation S8 and O-arm Surgical Navigation solution make a complex surgery seem more routine and free of any errors
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme
The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
The approval comes soon after Corbevax was given the nod for 12-15-year group
Subscribe To Our Newsletter & Stay Updated
